Literature DB >> 31770003

Nasal Nitric Oxide Measurement in Primary Ciliary Dyskinesia. A Technical Paper on Standardized Testing Protocols.

Adam J Shapiro1, Sharon D Dell2, Benjamin Gaston3, Michael O'Connor4, Nadzeya Marozkina5, Michele Manion6, Milan J Hazucha7,8, Margaret W Leigh9,10.   

Abstract

Nasal nitric oxide concentrations are extremely low in primary ciliary dyskinesia (PCD), and measurement of this nasal gas is recommended as a PCD diagnostic test in cooperative patients aged 5 years and older. However, nasal nitric oxide measurements must be performed with chemiluminescence analyzers using a standardized protocol to ensure proper results, because nasal nitric oxide values can be influenced by various internal and external factors. Repeat nasal nitric oxide testing on separate visits is required to ensure that low diagnostic values are persistent and consistent with PCD. This technical paper presents the standard operating procedures for nasal nitric oxide measurement used by the PCD Foundation Clinical and Research Centers Network at various specialty centers across North America. Adherence to this document ensures reliable nasal nitric oxide testing and high diagnostic accuracy when employed in a population with appropriate clinical phenotypes for PCD.

Entities:  

Keywords:  Kartagener syndrome; nasal nitric oxide; primary ciliary dyskinesia

Year:  2020        PMID： 31770003      PMCID： PMC6993796          DOI： 10.1513/AnnalsATS.201904-347OT

Source DB:  PubMed          Journal:  Ann Am Thorac Soc        ISSN： 2325-6621


  55 in total

Review 1.  Nitric oxide in primary ciliary dyskinesia.

Authors:  Woolf T Walker; Claire L Jackson; Peter M Lackie; Claire Hogg; Jane S Lucas
Journal:  Eur Respir J       Date:  2012-03-09       Impact factor: 16.671

2.  Role of exhaled nasal nitric oxide in distinguishing between chronic rhinosinusitis with and without nasal polyps.

Authors:  Chengyao Liu; Ming Zheng; Fei He; Xiangdong Wang; Luo Zhang
Journal:  Am J Rhinol Allergy       Date:  2017-09-19       Impact factor: 2.467

3.  Technical and practical issues for tidal breathing measurements of nasal nitric oxide in children.

Authors:  Nicole Beydon; Arnaud Chambellan; Corinne Alberti; Jacques de Blic; Annick Clément; Estelle Escudier; Muriel Le Bourgeois
Journal:  Pediatr Pulmonol       Date:  2015-03-02

4.  Respiratory manifestations in 38 patients with Alström syndrome.

Authors:  Caroline Boerwinkle; Jan D Marshall; Joy Bryant; William A Gahl; Kenneth N Olivier; Meral Gunay-Aygun
Journal:  Pediatr Pulmonol       Date:  2016-12-28

5.  Nasal Nitric Oxide in Primary Immunodeficiency and Primary Ciliary Dyskinesia: Helping to Distinguish Between Clinically Similar Diseases.

Authors:  Zofia N Zysman-Colman; Kimberley R Kaspy; Reza Alizadehfar; Keith R NyKamp; Maimoona A Zariwala; Michael R Knowles; Donald C Vinh; Adam J Shapiro
Journal:  J Clin Immunol       Date:  2019-03-26       Impact factor: 8.317

6.  Functional roles of nasal nitric oxide in nasal patency and mucociliary function.

Authors:  Masanobu Imada; Satoshi Nonaka; Yoshihumi Kobayashi; Jun Iwamoto
Journal:  Acta Otolaryngol       Date:  2002-07       Impact factor: 1.494

7.  Nasal nitric oxide and its relationship to nasal symptoms, smoking and nasal nitrate.

Authors:  A C Olin; J Hellgren; G Karlsson; G Ljungkvist; K Nolkrantz; K Torén
Journal:  Rhinology       Date:  1998-09       Impact factor: 3.681

8.  Diagnostic accuracy of nitric oxide measurements to detect primary ciliary dyskinesia.

Authors:  Mieke Boon; Isabelle Meyts; Marijke Proesmans; Francois L Vermeulen; Mark Jorissen; Kris De Boeck
Journal:  Eur J Clin Invest       Date:  2014-05       Impact factor: 4.686

9.  Infant nasal nitric oxide over time: natural evolution and impact of respiratory tract infection.

Authors:  June K Marthin; Maria C Philipsen; Susanne Rosthoj; Kim G Nielsen
Journal:  Eur Respir J       Date:  2018-06-21       Impact factor: 16.671

10.  Diagnostic accuracy of nasal nitric oxide for establishing diagnosis of primary ciliary dyskinesia: a meta-analysis.

Authors:  Panayiotis Kouis; Stefania I Papatheodorou; Panayiotis K Yiallouros
Journal:  BMC Pulm Med       Date:  2015-12-03       Impact factor: 3.317
View more
  11 in total

1.  Implementation of a screening tool for primary ciliary dyskinesia (PCD) in a pediatric otolaryngology clinic.

Authors:  Steven K Brennan; David Molter; Maithilee Menezes; Katherine Dunsky; David Leonard; Judith Lieu; Keiko Hirose; Guy Hazan; Amjad Horani; Thomas Ferkol; Steven L Brody
Journal:  Int J Pediatr Otorhinolaryngol       Date:  2020-12-31       Impact factor: 1.675

2.  Identification of Two Novel DNAAF2 Variants in Two Consanguineous Families with Primary Ciliary Dyskinesia.

Authors:  Chenyang Lu; Danhui Yang; Cheng Lei; Rongchun Wang; Ting Guo; Hong Luo
Journal:  Pharmgenomics Pers Med       Date:  2021-11-10

3.  Nasal nitric oxide measurement variability to establish a standard for reliable results.

Authors:  Nicole Beydon
Journal:  ERJ Open Res       Date:  2022-06-27

Review 4.  WAO-ARIA consensus on chronic cough - Part III: Management strategies in primary and cough-specialty care. Updates in COVID-19.

Authors:  Philip W Rouadi; Samar A Idriss; Jean Bousquet; Tanya M Laidlaw; Cecilio R Azar; Mona S Al-Ahmad; Anahi Yañez; Maryam Ali Y Al-Nesf; Talal M Nsouli; Sami L Bahna; Eliane Abou-Jaoude; Fares H Zaitoun; Usamah M Hadi; Peter W Hellings; Glenis K Scadding; Peter K Smith; Mario Morais-Almeida; René Maximiliano Gómez; Sandra N Gonzalez Diaz; Ludger Klimek; Georges S Juvelekian; Moussa A Riachy; Giorgio Walter Canonica; David Peden; Gary W K Wong; James Sublett; Jonathan A Bernstein; Lianglu Wang; Luciana K Tanno; Manana Chikhladze; Michael Levin; Yoon-Seok Chang; Bryan L Martin; Luis Caraballo; Adnan Custovic; Jose Antonio Ortego-Martell; Olivia J Ly Lesslar; Erika Jensen-Jarolim; Motohiro Ebisawa; Alessandro Fiocchi; Ignacio J Ansotegui
Journal:  World Allergy Organ J       Date:  2022-05-14       Impact factor: 5.516

5.  Feasibility of nasal NO screening in healthy newborns.

Authors:  Flurina Buechel; Jakob Usemann; A Aline; Peter Salfeld; Alexander Moeller; Andreas Jung
Journal:  Pediatr Pulmonol       Date:  2021-10-01

6.  Limitations of Nasal Nitric Oxide Testing in Primary Ciliary Dyskinesia.

Authors:  Adam J Shapiro; Stephanie D Davis; Margaret W Leigh; Michael R Knowles; Valery Lavergne; Thomas Ferkol
Journal:  Am J Respir Crit Care Med       Date:  2020-08-01       Impact factor: 21.405

Review 7.  Novel compound heterozygous mutations of DNAH5 identified in a pediatric patient with Kartagener syndrome: case report and literature review.

Authors:  Lina Wang; Xin Zhao; Hang Liang; Li Zhang; Chunyan Li; Deli Li; Xiangfeng Meng; Fanzheng Meng; Mao Gao
Journal:  BMC Pulm Med       Date:  2021-08-14       Impact factor: 3.317

8.  Diagnosis of primary ciliary dyskinesia: discrepancy according to different algorithms.

Authors:  Mirjam Nussbaumer; Elisabeth Kieninger; Stefan A Tschanz; Sibel T Savas; Carmen Casaulta; Myrofora Goutaki; Sylvain Blanchon; Andreas Jung; Nicolas Regamey; Claudia E Kuehni; Philipp Latzin; Loretta Müller
Journal:  ERJ Open Res       Date:  2021-11-01

9.  An international survey on nasal nitric oxide measurement practices for the diagnosis of primary ciliary dyskinesia.

Authors:  Nicole Beydon; Thomas Ferkol; Amanda Lea Harris; Murielle Colas; Stephanie D Davis; Eric Haarman; Claire Hogg; Emma Kilbride; Panayotis Kouis; Claudia E Kuehni; Philipp Latzin; Diana Marangu; June Marthin; Kim G Nielsen; Phil Robinson; Nisreen Rumman; Matthew Rutter; Woolf Walker; Jane S Lucas
Journal:  ERJ Open Res       Date:  2022-04-04

10.  Autosomal dominant variants in FOXJ1 causing primary ciliary dyskinesia in two patients with obstructive hydrocephalus.

Authors:  Adam J Shapiro; Kimberley Kaspy; M Leigh Ann Daniels; Jaclyn R Stonebraker; Van-Hung Nguyen; Lyne Joyal; Michael R Knowles; Maimoona A Zariwala
Journal:  Mol Genet Genomic Med       Date:  2021-06-15       Impact factor: 2.473
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.